Benuvia is delighted to announce a multi-year agreement to supply its Dronabinol API to a leading U.S. pharmaceutical company, marking a major step forward in cannabinoid innovation and CDMO excellence. “This partnership underscores Benuvia’s position as a trusted source of pharmaceutical-grade cannabinoid APIs,” said Terry Novak, CEO of Benuvia. Read the full press release here: https://lnkd.in/ezHCGe6h #Benuvia #CDMO #PharmaPartnership #CannabinoidAPI #Dronabinol #PharmaInnovation #API #ContractManufacturing #CDMO #DrugDevelopment #Cannabinoids #Dronabinol #ControlledSubstances #RegulatoryCompliance
Benuvia
Pharmaceutical Manufacturing
Round Rock, Texas 2,584 followers
Controlled Substance Solutions. Specialty Pharmaceutical CDMO. Made in the USA.
About us
At Benuvia, we help clients navigate the complexities of the development and manufacture of controlled substances for novel therapies, offering complete control over the drug development process. As a specialized CDMO offering small molecule API and finished dose development and cGMP manufacturing services, we specialize in the formulation, synthesis, and production of highly regulated and complex compounds, delivering end-to-end solutions tailored to our clients’ needs. We provide the expertise, process optimization, scale-up capabilities, and infrastructure to accelerate time-to-market while also reducing costs. Benuvia is a pioneer in the development and manufacturing of controlled substances with over 15 years of experience in cannabinoids, psychedelics, and other highly regulated compounds. We are the go-to partner for companies seeking high-quality products, robust regulatory compliance, and a first-class customer experience. Benuvia has been at the forefront of cannabinoid innovation since 2009, manufacturing pharmaceutical-grade, cGMP pure cannabidiol (CBD). Our expertise extends to other highly controlled substances, allowing us to support therapies in emerging fields like psychedelics. From formulation to API synthesis and robust analytical development to manufacturing, packaging, serialized labeling, warehousing, import and export capabilities, and regulatory affairs, Benuvia offers a comprehensive suite of solutions to meet your clinical and commercial goals. Located near Austin, TX, in Round Rock, our 83,000-square-foot, purpose built, state-of-the-art facility is DEA and FDA registered and fully compliant with cGMP standards, as well as the DEA, EPA, and OSHA. These certifications, along with our proven track record in controlled substances, ensure the highest levels of quality, safety, and compliance for your products. Benuvia helps you navigate the unique challenges of controlled substances with tailored global solutions. Reach out today.
- Website
-
http://www.benuvia.com
External link for Benuvia
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Round Rock, Texas
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Controlled Substances, Regulatory Services, Pharmaceutical Development , API Manufacturing, Analytical Development, Analytical Testing, Liquid Fill, Psychedelics, Cannabinoids, D9THC, CBC, and CBG
Locations
-
Primary
Get directions
3950 N Mays St
Round Rock, Texas 78665, US
Employees at Benuvia
Updates
-
Benuvia reposted this
Benuvia is thrilled to be part of CPHI Americas 2025. Schedule your meeting with us today and visit us at stand 1142! https://lnkd.in/eZdmfRzd #Benuvia #CPHI #PharmaInnovation #Cannabinoids
-
-
Benuvia is thrilled to be part of CPHI Americas 2025. Schedule your meeting with us today and visit us at stand 1142! https://lnkd.in/eZdmfRzd #Benuvia #CPHI #PharmaInnovation #Cannabinoids
-
-
Exciting news! Benuvia and Trait Biosciences have joined forces in a strategic R&D and manufacturing agreement. This powerful collaboration combines Trait's cutting-edge cannabinoid science with Benuvia's proven development and manufacturing expertise. "Trait has established a solid reputation in the cannabinoid industry, and we are pleased to partner with their team on this project," said Terry Novak, CEO of Benuvia. Read the full press release: https://lnkd.in/e_UQ2xP8 #Benuvia #TraitBiosciences #Cannabinoids #Innovation #CDMO
-
Ready to take your talents to new heights? You’ll do more than work here—you’ll make a difference. Join a team where your expertise and ambition drive innovation in pharmaceuticals. Gina Amaya, PHR, SHRM-CP is #hiring. Know anyone who might be interested?
-
We’re #hiring. Know anyone who might be interested and would be a good fit?
-
Join Benuvia at the World Orphan Drug Congress 2025 in Boston, MA, from April 22-24! Visit us at Booth #431 to learn about our innovative, purpose-built unified platform designed specifically for API and drug product development & manufacturing. Our CEO and subject matter experts are excited to meet you, discuss your unique challenges, and explore how Benuvia's small molecule and controlled substance solutions can streamline your processes and accelerate your journey to market. Schedule your meeting today—we look forward to connecting with you at the event! #WorldOrphanDrugCongress #WODC2025 #DrugDevelopment #ControlledSubstances #RareDiseases #Pharma #Innovation #CDMO #APIs
-
Benuvia is proud to announce a five-year NIH contract to produce GMP-grade psilocybin and other bulk drug substances—advancing the development of innovative therapies for mental health and substance use disorders. “This contract highlights our leadership in the development and manufacturing of controlled substances under GMP conditions,” said Terry Novak, CEO of Benuvia. Read the full press release here: https://lnkd.in/edSZsVkN #Benuvia #NIH #GMP #CDMO #PsychedelicResearch #MentalHealthInnovation #PharmaceuticalManufacturing #Psilocybin #NIDA #ControlledSubstances #LifeScience #DrugDevelopment
-
-
Benuvia is proud to announce Brazil’s National Health Surveillance Agency (ANVISA) has officially certified Benuvia for Good Manufacturing Practices (GMP). This certification enables Benuvia to manufacture and distribute non-sterile liquid pharmaceutical products in Brazil, the largest healthcare market in Latin America. Achieving ANVISA’s rigorous standards underscores our commitment to providing high-quality, compliant pharmaceutical manufacturing solutions tailored to Brazil’s rapidly growing healthcare sector. We look forward to partnering with both local and international pharmaceutical companies to bring life-changing therapies to patients in need. Read the press release here: https://lnkd.in/eYBKRjJC #ANVISA #GMP #PharmaceuticalManufacturing #BrazilHealthcare #Benuvia #LifeChangingTherapies
-
Benuvia is proud to announce Brazil’s National Health Surveillance Agency (ANVISA) has officially certified Benuvia for Good Manufacturing Practices (GMP). This certification enables Benuvia to manufacture and distribute non-sterile liquid pharmaceutical products in Brazil, the largest healthcare market in Latin America. Achieving ANVISA’s rigorous standards underscores our commitment to providing high-quality, compliant pharmaceutical manufacturing solutions tailored to Brazil’s rapidly growing healthcare sector. We look forward to partnering with both local and international pharmaceutical companies to bring life-changing therapies to patients in need. Read the press release here: https://lnkd.in/eYBKRjJC #ANVISA #GMP #PharmaceuticalManufacturing #BrazilHealthcare #Benuvia #LifeChangingTherapies